• 1
    Wong WT, Chew EY. Ocular von Hippel–Lindau disease: clinical update and emerging treatments. Curr Opin Ophthalmol 2008; 19: 213217.
  • 2
    Wong WT, Agrón E, Coleman HR, Tran T, Reed GF, Csaky K, Chew EY. Clinical characterization of retinal capillary hemangioblastomas in a large population of patients with von Hippel–Lindau disease. Ophthalmology 2008; 115: 181188.
  • 3
    Wong WT, Liang KJ, Hammel K, Coleman HR, Chew EY. Intravitreal ranibizumab therapy for retinal capillary hemangioblastoma related to von Hippel–Lindau disease. Ophthalmology 2008; 115: 19571964.
  • 4
    Chan CC, Collins AB, Chew EY. Molecular pathology of eyes with von Hippel–Lindau (VHL) disease: a review. Retina 2007; 27: 17.
  • 5
    Sakata LM, Deleon-Ortega J, Sakata V, Girkin CA. Optical coherence tomography of the retina and optic nerve—a review. Clin Experiment Ophthalmol 2009; 37: 9099.
  • 6
    Paunescu LA, Schuman JS, Price LL, Stark PC, Beaton S, Ishikawa H, Wollstein G et al. Reproducibility of nerve fiber thickness, macular thickness and optic nerve head measurements using StratusOCT. Invest Ophthalmol Vis Sci 2004; 45: 17161724.
  • 7
    Chin EK, Trikha R, Morse LS, Zawadzki RJ, Werner JS, Park SS. Optical coherence tomography findings of exophytic retinal capillary hemangiomas of the posterior pole. Ophthalmic Surg Lasers Imaging 2010; doi: 10.3928/15428877-20100215-30. [Epub ahead of print].